TGA
MJN

Trilogy Global Advisors’s Mead Johnson Nutrition Company MJN Stock Holding History

Trilogy Global Advisors’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-71,329
Closed -$5.05M – 77
2016
Q4 		$5.05M Buy
71,329
+70
+0.1% +$5.22K 0.17% 69
2016
Q3 		$5.63M Buy
+71,259
New +$6.08M 0.19% 75

Other funds holding MJN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $20.5B AUM 26.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Trilogy Global Advisors's MJN Position: Q1 2017 in Review

Trilogy Global Advisors sold out of Mead Johnson Nutrition Company (MJN) in Q1 2017, closing a stake of 71,329 shares — an estimated $5.05M sold.

Trilogy Global Advisors first reported a position in MJN in Q3 2016 and held it in 2 quarters. The position peaked at $5.63M in Q3 2016. 533 funds tracked by Wall St. Rank hold MJN as of Q1 2017.

  • Trilogy Global Advisors reported no remaining Mead Johnson Nutrition Company position as of Q1 2017 after selling out during the quarter.
  • Trilogy Global Advisors sold 71,329 Mead Johnson Nutrition Company shares in Q1 2017, an estimated $5.05M.
  • Trilogy Global Advisors first reported a position in Mead Johnson Nutrition Company in Q3 2016 and held it in 2 quarters.
  • Trilogy Global Advisors's Mead Johnson Nutrition Company position peaked at $5.63M in Q3 2016.
  • 533 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2017.

Based on Trilogy Global Advisors's 13F filing for Q1 2017, filed 12 May 2017.